Ai J, Zhang H, Zhang Y, Lin K, Zhang Y, Wu J, Wan Y, Huang Y, Song J, Fu Z, Wang H, Guo J, Jiang N, Fan M, Zhou Y, Zhao Y, Zhang Q, Liu Q, Lv J, Li P, Qiu C, Zhang W (2022) Omicron variant showed lower neutralizing sensitivity than other SARS-CoV-2 variants to immune sera elicited by vaccines after boost. Emerg Microbes Infect 11(1):337–343

Article  CAS  PubMed  PubMed Central  Google Scholar 

Amanat F, Thapa M, Lei T, Ahmed SMS, Adelsberg DC, Carreno JM, Strohmeier S, Schmitz AJ, Zafar S, Zhou JQ, Rijnink W, Alshammary H, Borcherding N, Reiche AG, Srivastava K, Sordillo EM, van Bakel H, Personalized Virology I, Turner JS, Bajic G, Simon V, Ellebedy AH, Krammer F (2021) SARS-CoV-2 mRNA vaccination induces functionally diverse antibodies to NTD, RBD, and S2. Cell 184(15):3936–3948

Article  CAS  PubMed  PubMed Central  Google Scholar 

Arbel R, Peretz A, Sergienko R, Friger M, Beckenstein T, Duskin-Bitan H, Yaron S, Hammerman A, Bilenko N, Netzer D (2023) Effectiveness of a bivalent mRNA vaccine booster dose to prevent severe COVID-19 outcomes: a retrospective cohort study. Lancet Infect Dis 23(8):914–921

Article  CAS  PubMed  Google Scholar 

Carreno JM, Alshammary H, Tcheou J, Singh G, Raskin AJ, Kawabata H, Sominsky LA, Clark JJ, Adelsberg DC, Bielak DA, Gonzalez-Reiche AS, Dambrauskas N, Vigdorovich V, Group P-PS, Srivastava K, Sather DN, Sordillo EM, Bajic G, van Bakel H, Simon V, Krammer F (2022) Activity of convalescent and vaccine serum against SARS-CoV-2 Omicron. Nature 602(7898):682–688

Article  CAS  PubMed  Google Scholar 

Chen S, Guan F, Candotti F, Benlagha K, Camara NOS, Herrada AA, James LK, Lei J, Miller H, Kubo M, Ning Q, Liu C (2022) The role of B cells in COVID-19 infection and vaccination. Front Immunol 13:988536

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chi WY, Li YD, Huang HC, Chan TEH, Chow SY, Su JH, Ferrall L, Hung CF, Wu TC (2022) COVID-19 vaccine update: vaccine effectiveness, SARS-CoV-2 variants, boosters, adverse effects, and immune correlates of protection. J Biomed Sci 29(1):82

Article  PubMed  PubMed Central  Google Scholar 

Dai L, Zheng T, Xu K, Han Y, Xu L, Huang E, An Y, Cheng Y, Li S, Liu M, Yang M, Li Y, Cheng H, Yuan Y, Zhang W, Ke C, Wong G, Qi J, Qin C, Yan J, Gao GF (2020) A universal design of betacoronavirus vaccines against COVID-19, MERS, and SARS. Cell 182(3):722–733

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dhawan M, Rabaan AA, Fawarah MMA, Almuthree SA, Alsubki RA, Alfaraj AH, Mashraqi MM, Alshamrani SA, Abduljabbar WA, Alwashmi ASS, Ibrahim FA, Alsaleh AA, Khamis F, Alsalman J, Sharma M, Emran TB (2023) Updated insights into the T cell-mediated immune response against SARS-CoV-2: a step towards efficient and reliable vaccines. Vaccines (Basel) 11(1):101

Article  CAS  PubMed  Google Scholar 

Gao F, Huang J, Li T, Hu C, Shen M, Mu S, Luo F, Song S, Hao Y, Wang W, Han X, Qian C, Wang Y, Wu R, Li L, Li S, Jin A (2021) A highly conserved peptide vaccine candidate activates both humoral and cellular immunity against SARS-CoV-2 variant strains. Front Immunol 12:789905

Article  CAS  PubMed  PubMed Central  Google Scholar 

Gomez CE, Perdiguero B, Esteban M (2021) Emerging SARS-CoV-2 variants and impact in global vaccination programs against SARS-CoV-2/COVID-19. Vaccines (Basel) 9(3):243

Article  CAS  PubMed  Google Scholar 

Guo K, Ni P, Chang S, Jin Y, Duan G, Zhang R (2023) Effectiveness of mRNA vaccine against Omicron-related infections in the real world: a systematic review and meta-analysis. Am J Infect Control 51(9):1049–1055

Article  CAS  PubMed  Google Scholar 

Hattab D, Amer MFA, Al-Alami ZM, Bakhtiar A (2024) SARS-CoV-2 journey: from alpha variant to omicron and its sub-variants. Infection 52(3):767–786

Article  CAS  PubMed  PubMed Central  Google Scholar 

He X, He C, Hong W, Yang J, Wei X (2023) Research progress in spike mutations of SARS-CoV-2 variants and vaccine development. Med Res Rev 43(4):932–971

Article  CAS  PubMed  Google Scholar 

Hurlburt NK, Homad LJ, Sinha I, Jennewein MF, MacCamy AJ, Wan YH, Boonyaratanakornkit J, Sholukh AM, Jackson AM, Zhou P, Burton DR, Andrabi R, Ozorowski G, Ward AB, Stamatatos L, Pancera M, McGuire AT (2022) Structural definition of a pan-sarbecovirus neutralizing epitope on the spike S2 subunit. Commun Biol 5(1):342

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jain N, Shankar U, Majee P, Kumar A (2021) Scrutinizing the SARS-CoV-2 protein information for designing an effective vaccine encompassing both the T-cell and B-cell epitopes. Infect Genet Evol 87:104648

Article  CAS  PubMed  Google Scholar 

Kuhlmann C, Mayer CK, Claassen M, Maponga T, Burgers WA, Keeton R, Riou C, Sutherland AD, Suliman T, Shaw ML, Preiser W (2022) Breakthrough infections with SARS-CoV-2 omicron despite mRNA vaccine booster dose. Lancet 399(10325):625–626

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lai GC, Chao TL, Lin SY, Kao HC, Tsai YM, Lu DC, Chiang YW, Chang SY, Chang SC (2022) Neutralization or enhancement of SARS-CoV-2 infection by a monoclonal antibody targeting a specific epitope in the spike receptor-binding domain. Antiviral Res 200:105290

Article  CAS  PubMed  PubMed Central  Google Scholar 

Lan J, Ge J, Yu J, Shan S, Zhou H, Fan S, Zhang Q, Shi X, Wang Q, Zhang L, Wang X (2020) Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor. Nature 581(7807):215–220

Article  CAS  PubMed  Google Scholar 

Li CJ, Chang SC (2023) SARS-CoV-2 spike S2-specific neutralizing antibodies. Emerg Microbes Infect 12(2):2220582

Article  PubMed  PubMed Central  Google Scholar 

Li T, Kan Q, Ge J, Wan Z, Yuan M, Huang Y, Xie Q, Yang Y, Shao H, Li X, Ye L, Qin A, Bu Z, Liu P, Ye J (2021) A novel linear and broadly neutralizing peptide in the SARS-CoV-2 S2 protein for universal vaccine development. Cell Mol Immunol 18(11):2563–2565

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li CJ, Chao TL, Chang TY, Hsiao CC, Lu DC, Chiang YW, Lai GC, Tsai YM, Fang JT, Ieong S, Wang JT, Chang SY, Chang SC (2022a) Neutralizing monoclonal antibodies inhibit SARS-CoV-2 infection through blocking membrane fusion. Microbiol Spectr 10(2):e0181421

Article  PubMed  Google Scholar 

Li L, Wei Y, Yang H, Yan J, Li X, Li Z, Zhao Y, Liang H, Wang H (2022b) Advances in next-generation coronavirus vaccines in response to future virus evolution. Vaccines (Basel) 10(12):2035

Article  CAS  PubMed  Google Scholar 

Liang Y, Zhang J, Yuan RY, Wang MY, He P, Su JG, Han ZB, Jin YQ, Hou JW, Zhang H, Zhang XF, Shao S, Hou YN, Liu ZM, Du LF, Shen FJ, Zhou WM, Xu K, Gao RQ, Tang F, Lei ZH, Liu S, Zhen W, Wu JJ, Zheng X, Liu N, Chen S, Ma ZJ, Zheng F, Ren SY, Hu ZY, Huang WJ, Wu GZ, Ke CW, Li QM (2022) Design of a mutation-integrated trimeric RBD with broad protection against SARS-CoV-2. Cell Discov 8(1):17

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu Y, Rocklov J (2021) The reproductive number of the Delta variant of SARS-CoV-2 is far higher compared to the ancestral SARS-CoV-2 virus. J Travel Med 28(7):taab124

Article  PubMed  PubMed Central  Google Scholar 

Liu Y, Rocklov J (2022) The effective reproductive number of the Omicron variant of SARS-CoV-2 is several times relative to Delta. J Travel Med 29(3):taac037

Article  PubMed  PubMed Central  Google Scholar 

Manathunga SS, Abeyagunawardena IA, Dharmaratne SD (2023) A comparison of transmissibility of SARS-CoV-2 variants of concern. Virol J 20(1):59

Article  CAS  PubMed  PubMed Central  Google Scholar 

Moss P (2022) The T cell immune response against SARS-CoV-2. Nat Immunol 23(2):186–193

Article  CAS